Chamorro David, Alarcón Lourdes, Ponce Arturo, Tapia Rocio, González-Aguilar Héctor, Robles-Flores Martha, Mejía-Castillo Teresa, Segovia José, Bandala Yamir, Juaristi Eusebio, González-Mariscal Lorenza
Departments of Physiology, Biophysics, and Neuroscience, Center for Research and Advanced Studies (CINVESTAV), Mexico, D.F., 07360, Mexico.
Mol Biol Cell. 2009 Sep;20(18):4120-9. doi: 10.1091/mbc.e08-11-1129. Epub 2009 Jul 22.
Here, we have analyzed the subcellular destiny of newly synthesized tight junction protein zona occludens (ZO)-2. After transfection in sparse cells, 74% of cells exhibit ZO-2 at the nucleus, and after 18 h the value decreases to 17%. The mutation S369A located within the nuclear exportation signal 1 of ZO-2 impairs the nuclear export of the protein. Because Ser369 represents a putative protein kinase C (PKC) phosphorylation site, we tested the effect of PKC inhibition and stimulation on the nuclear export of ZO-2. Our results strongly suggest that the departure of ZO-2 from the nucleus is regulated by phosphorylation at Ser369 by novel PKCepsilon. To test the route taken by ZO-2 from synthesis to the plasma membrane, we devised a novel nuclear microinjection assay in which the nucleus served as a reservoir for anti-ZO-2 antibody. Through this assay, we demonstrate that a significant amount of newly synthesized ZO-2 goes into the nucleus and is later relocated to the plasma membrane. These results constitute novel information for understanding the mechanisms that regulate the intracellular fate of ZO-2.
在此,我们分析了新合成的紧密连接蛋白闭合蛋白(ZO)-2的亚细胞命运。在稀疏细胞中转染后,74%的细胞在细胞核中呈现ZO-2,18小时后该值降至17%。位于ZO-2核输出信号1内的S369A突变会损害该蛋白的核输出。由于Ser369代表一个假定的蛋白激酶C(PKC)磷酸化位点,我们测试了PKC抑制和刺激对ZO-2核输出的影响。我们的结果强烈表明,新型PKCε通过Ser369的磷酸化来调节ZO-2从细胞核的离开。为了测试ZO-2从合成到质膜所采取的途径,我们设计了一种新型核显微注射试验,其中细胞核作为抗ZO-2抗体的储存库。通过该试验,我们证明大量新合成的ZO-进入细胞核,随后重新定位到质膜。这些结果为理解调节ZO-2细胞内命运的机制提供了新信息。